MiR-29c suppresses invasion and metastasis by targeting TIAM1 in nasopharyngeal carcinoma

Cancer Letters

Volumn 329, Issue 2, 2013, Pages 181-188

  Liu, Na ^a   Tang, Ling Long ^a   Sun, Ying ^a   Cui, Rui Xue ^a   Wang, Hui Yun ^a   Huang, Bi Jun ^a   He, Qing Mei ^a   Jiang, Wei ^a   Ma, Jun ^a  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

Author keywords

Invasion; Metastasis; MiR 29c; Nasopharyngeal carcinoma; TIAM1

Indexed keywords

GUANINE NUCLEOTIDE EXCHANGE FACTOR; LUCIFERASE; MICRORNA; MICRORNA 29C; T CELL LYMPHOMA INVASION AND METASTASIS 1 PROTEIN; UNCLASSIFIED DRUG;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CANCER PROGNOSIS; CANCER SURVIVAL; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DOWN REGULATION; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; LUNG METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS FREE SURVIVAL; METASTASIS INHIBITION; MOLECULAR INTERACTION; MOLECULAR PATHOLOGY; MOUSE; NASOPHARYNX CARCINOMA; NONHUMAN; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN RNA BINDING; PROTEIN TARGETING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING; WOUND HEALING;

3' UNTRANSLATED REGIONS; ADULT; ANIMALS; BASE SEQUENCE; BINDING SITES; CARCINOMA; CELL LINE, TUMOR; CELL MOVEMENT; DOWN-REGULATION; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; GUANINE NUCLEOTIDE EXCHANGE FACTORS; HUMANS; KAPLAN-MEIER ESTIMATE; LUNG NEOPLASMS; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; MICRORNAS; MIDDLE AGED; MULTIVARIATE ANALYSIS; NASOPHARYNGEAL NEOPLASMS; NEOPLASM INVASIVENESS; NEOPLASM TRANSPLANTATION; PROPORTIONAL HAZARDS MODELS; RNA INTERFERENCE;

EID: 84872500497     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2012.10.032     Document Type: Article

References (43)

1. Jemal A., Bray F., Center M.M., Ferlay J., Ward E., Forman D. Global cancer statistics. C.A. Cancer J. Clin. 2011, 61:69-90.
2. Ma B.B., Hui E.P., Chan A.T. Systemic approach to improving treatment outcome in nasopharyngeal carcinoma: current and future directions. Cancer Sci. 2008, 99:1311-1318.
3. Lai S.Z., Li W.F., Chen L., Luo W., Chen Y.Y., Liu L.Z., Sun Y., Lin A.H., Liu M.Z., Ma J. How does intensity-modulated radiotherapy versus conventional two-dimensional radiotherapy influence the treatment results in nasopharyngeal carcinoma patients. Int. J. Radiat. Oncol. Biol. Phys. 2011, 80:661-668.
4. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297.
5. Ambros V. MciroRNA pathways in flies and worms: growth, death, fat, stress, and timing. Cell 2003, 113:673-676.
6. Esquela-Kerscher A., Slack F.J. Oncomirs-microRNAs with a role in cancer. Nat. Rev. Cancer 2006, 6:259-269.
7. Calin G.A., Sevignani C., Dumitru C.D., Hyslop T., Noch E., Yendamuri S., Shimizu M., Rattan S., Bullrich F., Negrini M., Croce C.M. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc. Natl. Acad. Sci. USA 2004, 101:2999-3004.
8. He L., Thomson J.M., Hemann M.T., Hernando-Monge E., Mu D., Goodson S., Powers S., Cordon-Cardo C., Lowe S.W., Hannon G.J., Hammond S.M. A microRNA polycistron as a potential human oncogenes. Nature 2005, 435:828-833.
9. Lu J., Getz G., Miska E.A., Alvarez-Saavedra E., Lamb J., Peck D., Sweet-Cordero A., Ebert B.L., Mak R.H., Ferrando A.A., Downing J.R., Jacks T., Horvitz H.R., Golub T.R. MicroRNA expression profiles classify human cancers. Nature 2005, 435:834-838.
10. Calin G.A., Croce C.M. MicroRNA signatures in human cancers. Nat. Rev. Cancer 2006, 6:857-866.
11. Sengupta S., den Boon J.A., Chen I.H., Newton M.A., Stanhope S.A., Cheng Y.J., Chen C.J., Hildesheim A., Sugden B., Ahlguist P. MicroRNA 29c is down-regulated in nasopharyngeal carcinomas, up-regulating mRNAs encoding extracellular matrix proteins. Proc. Natl. Acad. Sci. USA 2008, 105:5874-5878.
12. Chen H.C., Chen G.H., Chen Y.H., Liao W.L., Liu C.Y., Chang K.P., Chang Y.S., Chen S.J. MicroRNA deregulation and pathway alterations in nasopharyngeal carcinoma. Br. J. Cancer 2009, 100:1002-1011.
13. Li T., Chen J.X., Fu X.P., Yang S., Zhang Z., Chen K.H., Li Y. MicroRNA expression profiling of nasopharyngeal carcinoma. Oncol. Rep. 2011, 25:1353-1363.
14. Lu J., He M.L., Wang L., Chen Y., Liu X., Dong Q., Chen Y.C., Peng Y., Yao K.T., Kung H.F., Li X.P. MiR-26a inhibits cell growth and tumorigenesis of nasopharyngeal carcinoma through repression of EZH. Cancer Res. 2011, 71:225-233.
15. Hui A.B., Bruce J.P., Alajez N.M., Shi W., Yue S., Perez-Ordonez B., Xu W., O'Sullivan B., Waldron J., Cummings B., Gullane P., Siu L., Liu F.F. Significance of dysregulated metadherin and microRNA-375 in head and neck cancer. Clin. Cancer Res. 2011, 17:7539-7550.
16. Xia H., Cheung W.K., Sze J., Lu G., Jiang S., Yao H., Bian X.W., Poon W.S., Kung H.F., Lin M.C. MiR-200a regulates epithelial-mesenchymal to stem-like transition via ZEB2 and beta-catenin signaling. J. Biol. Chem. 2010, 285:36995-37004.
17. Zhang L., Deng T., Li X., Liu H., Zhou H., Ma J., Wu M., Zhou M., Shen S., Li X., Niu Z., Zhang W., Shi L., Xiang B., Lu J., Wang L., Li D., Tang H., Li G. MicroRNA-141 is involved in a nasopharyngeal carcinoma-related genes network. Carcinogenesis 2010, 31:559-566.
18. Shi W., Alajez N.M., Bastianutto C., Hui A.B., Mocanu J.D., Ito E., Busson P., Lo K.W., Ng R., Waldron J., O'Sullivan B., Liu F.F. Significance of PIk1 regulation by miR-100 in human nasopharyngeal cancer. Int. J. Cancer 2010, 126:2036-2048.
19. Liu N., Chen N.Y., Cui R.X., Li W.F., Li Y., Wei R.R., Zhang M.Y., Sun Y., Huang B.J., Chen M., He Q.M., Jiang N., Chen L., Cho W.C., Yun J.P., Zeng J., Liu L.Z., Li L., Guo Y., Wang H.Y., Ma J. Prognostic value of a microRNA signature in nasopharyngeal carcinoma: a microRNA expression analysis. Lancet Oncol. 2012, 13:633-641.
20. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001, 25:402-408.
21. Mo Y.Y., Beck W.T. Association of human DNA topoisomerase II alpha with mitotic chromosomes in mammalian cells is independent of its catalytic activity. Exp. Cell Res. 1999, 252:50-62.
22. Lewis B.P., Burge C.B., Bartel D.P. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005, 120:15-20.
23. John B., Enright A.J., Aravin A., Tuschl T., Sander C., Marks D.S. Human microRNA targets. PLoS Biol. 2004, 2:e363.
24. Xu K., Rajagopal S., Klebba I., Dong S., Ji Y., Liu J., Kuperwasser C., Garlick J.A., Naber S.P., Buchsbaum R.J. The role of fibroblast Tiam1 in tumor cell invasion and metastasis. Oncogene 2010, 29:6533-6542.
25. Uhlenbrock K., Eberth A., Herbrand U., Daryab N., Stege P., Meier F., Friedl P., Collard J.G., Ahmadian M.R. The RacGEF Tiam1 inhibits migration and invasion of metastatic melanoma via a novel adhesive mechanism. J. Cell Sci. 2004, 117:4863-4871.
26. Fidler I.J. The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nat. Rev. Cancer 2003, 3:453-458.
27. Steeg P.S. Tumor metastasis: mechanistic insights and clinical challenges. Nat. Med. 2006, 12:895-904.
28. Kong Y.W., Ferland-McCollough D., Jackson T.J., Bushell M. MicroRNAs in cancer management. Lancet Oncol. 2012, 13:e249-258.
29. Le X.F., Merchant O., Bast R.C., Calin G.A. The roles of microRNAs in the cancer invasion-metastasis cascade. Cancer Microenviron 2010, 3:137-147.
30. Xiong Y.J., Fang J.H., Yun J.P., Yang J., Zhang Y., Jia W.H., Zhuang S.M. Effects of microRNA-29 on apoptosis, tumorigenicity, and prognosis of hepatocellular carcinoma. Hepatology 2010, 51:836-845.
31. Li Y., Wang F.F., Xu J.F., Ye F., Shen Y.M., Zhou J.S., Lu W.G., Wan X.Y., Ma D., Xie X. Progressive miRNA expression profiles in cervical carcinogenesis and identification of HPV-related target genes for miR-29. J. Pathol. 2011, 224:484-495.
32. Ding D.P., Chen Z.L., Zhao X.H., Wang J.W., Sun J., Wang Z., Tan F.W., Tan X.G., Li B.Z., Zhou F., Shao K., Li N., Qiu B., He J. MiR-29c induces cell cycle arrest in esophageal squamous cell carcinoma by modulating cyclin E expression. Carcinogenesis 2011, 32:1025-1032.
33. Pekarsky Y., Santanam U., Cimmino A., Palamarchuk A., Efanov A., Maximov V., Volinia S., Alder H., Liu C.G., Rassenti L., Calin G.A., Hagan J.P., Kipps T., Croce C.M. Tcl1 expression in chronic lymphocytic leukemia is regulated by miR-29 and miR-181. Cancer Res. 2006, 15:11590-11593.
34. Nguyen T., Kuo C., Nicholl M.B., Sim M.S., Turner R.R., Morton D.L., Hoon D.S. Downregulation of microRNA-29c is associated with hypermethylation of tumor-related genes and disease outcome in cutaneous melanoma. Epigenetics 2011, 6:388-394.
35. Park S.Y., Lee J.H., Ha M., Nam J.W., Kim V.N. Mir-29 miRNAs activate p53 by targeting p85 alpha and CDC42. Nat. Struct. Mol. Biol. 2009, 16:23-29.
36. Habets G.G., van der Kammen R.A., Stam J.C., Michiels F., Collard J.G. Sequence of the human invasion-inducing TIAM1 gene, its conservation in evolution and its expression in tumor cell lines of different tissue origin. Oncogene 1995, 10:1371-1376.
37. Mertens A.E., Roovers R.C., Collard J.G. Regulation of Tiam1-Rac signaling. FFBS Lett. 2003, 546:11-16.
38. Minard M.E., Kim L.S., Price J.E., Gallick G.E. The role of the guanine nucleotide exchange factor Tiam1 in cellular migration, invasion, adhesion and tumor progression. Breast Cancer Res. Treat. 2004, 84:21-32.
39. Minard M.E., Herynk M.H., Collard J.G., Gallick G.E. The guanine nucleotide exchange factor Tiam1 increases colon carcinoma growth at metastatic sites in an orthotropic nude mouse model. Oncogene 2005, 24:2568-2573.
40. Engers R., Mueller M., Walter A., Collard J.G., Willers R., Gabbert H.E. Prognostic relevance of Tiam1 protein expression in prostate carcinomas. Br. J. Cancer 2006, 95:1081-1086.
41. Ding Y., Chen B., Wang S., Zhao L., Chen L., Ding Y., Chen L., Luo R. Overexpression of Tiam1 in hepatocellular carcinomas predicts poor prognosis of HCC patients. Int. J. Cancer 2009, 124:653-658.
42. Liu H.M., Shi G.R., Liu X.L., Wu H., Fan Q.X., Wang X. Overexpression of Tiam1 predicts poor prognosis in patients with esophageal squamous cell carcinoma. Oncol. Rep. 2011, 25:841-848.
43. Zhao L., Liu Y.W., Sun X.G., He M.Y., Ding Y.Q. Overexpression of T lymphoma invasion and metastasis 1 predict renal cell carcinoma metastasis and overall patient survival. J. Cancer Res. Clin. Oncol. 2011, 137:393-398.